Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
CALL
CenterPoint Energy
CNP
$26.8B
| $903K | ﹤0.01% |
30,900
-8,000
| -21% | -$231K |
|
3052
Kinsale Capital Group
KNSL
$8.45B
| $903K | ﹤0.01% |
20,935
-4,538
| -18% | -$177K |
|
|
MFLA
3053
DELISTED
iPath Long Enhanced MSCI EAFE Index ETN
MFLA
| $903K | ﹤0.01% |
9,327
| – | – |
|
|
BNY
3054
PUT
Bank of New York Mellon
BNY
$108B
| $901K | ﹤0.01% |
17,000
+2,000
| +13% | +$105K |
|
|
AVXS
3055
DELISTED
AveXis, Inc. Common Stock
AVXS
| $901K | ﹤0.01% |
9,313
+9,298
| +61,987% | +$839K |
|
3056
PUT
Opko Health
OPK
$1.01B
| $900K | ﹤0.01% |
131,200
+63,200
| +93% | +$398K |
|
|
HEP
3057
DELISTED
Holly Energy Partners, L.P.
HEP
| $900K | ﹤0.01% |
26,936
+9,468
| +54% | +$315K |
|
3058
CALL
Flowserve
FLS
$10.1B
| $894K | ﹤0.01% |
21,000
+15,300
| +268% | +$643K |
|
3059
Cullen/Frost Bankers
CFR
$10.3B
| $891K | ﹤0.01% |
9,385
-6,954
| -43% | -$629K |
|
3060
Vanda Pharmaceuticals
VNDA
$306M
| $891K | ﹤0.01% |
49,788
+30,366
| +156% | +$508K |
|
3061
Essential Utilities
WTRG
$11.2B
| $891K | ﹤0.01% |
26,835
-576
| -2% | -$19.3K |
|
|
ARRS
3062
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $891K | ﹤0.01% |
31,261
-22,595
| -42% | -$626K |
|
3063
Pathward Financial
CASH
$1.89B
| $890K | ﹤0.01% |
34,077
+33,324
| +4,425% | +$860K |
|
3064
CALL
Match Group
MTCH
$8.9B
| $890K | ﹤0.01% |
38,400
+28,300
| +280% | +$571K |
|
3065
PUT
Patterson-UTI
PTEN
$3.62B
| $888K | ﹤0.01% |
42,400
-100
| -0.2% | -$1.84K |
|
|
ALE
3066
DELISTED
Allete
ALE
| $886K | ﹤0.01% |
11,464
-6,895
| -38% | -$516K |
|
3067
CALL
Hilton Worldwide
HLT
$73B
| $886K | ﹤0.01% |
12,759
+5,800
| +83% | +$370K |
|
3068
Jack in the Box
JACK
$351M
| $886K | ﹤0.01% |
8,691
+1,745
| +25% | +$167K |
|
3069
Ingevity
NGVT
$2.65B
| $886K | ﹤0.01% |
14,178
+616
| +5% | +$36.5K |
|
3070
PUT
HealthEquity
HQY
$8.73B
| $885K | ﹤0.01% |
17,500
-20,900
| -54% | -$973K |
|
3071
International Seaways
INSW
$4.49B
| $885K | ﹤0.01% |
44,914
-29,758
| -40% | -$608K |
|
|
UPL
3072
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $883K | ﹤0.01% |
101,913
-50,364
| -33% | -$460K |
|
3073
MarineMax
HZO
$793M
| $882K | ﹤0.01% |
53,279
+46,685
| +708% | +$762K |
|
3074
CALL
Travelers Companies
TRV
$79.8B
| $882K | ﹤0.01% |
7,200
-4,600
| -39% | -$574K |
|
|
GRA
3075
CALL
DELISTED
W.R. Grace & Co.
GRA
| $880K | ﹤0.01% |
12,200
+10,000
| +455% | +$706K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.